Different vitamin D receptor agonists exhibit differential effects on endothelial function and aortic gene expression in 5/6 nephrectomized rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 148, Issue , 2015, Pages 202-209

  Wu Wong, J Ruth ^a,c   Li, Xinmin ^b   Chen, Yung Wu ^a  

^a Vidasym   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c 2201 W ^*  (United States)

Author keywords

Alfacalcidol; Aortic gene expression; Endothelial function; Kidney disease; Paricalcitol; Vitamin D analogs; Vitamin D receptor; VS 105

Indexed keywords

ABRA PROTEIN; ACETYLCHOLINE; ALFACALCIDOL; APOLIPOPROTEIN A4; CALCIUM; DNA; FATTY ACID BINDING PROTEIN 2; HSD17B2 PROTEIN; HSPA1B PROTEIN; NITROPRUSSIDE SODIUM; PARATHYROID HORMONE; PARICALCITOL; PHENYLEPHRINE; PROTEIN; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VS 105; CALCITRIOL; CALCITRIOL RECEPTOR; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; BLOOD VESSEL FUNCTION; CALCIUM BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DNA MICROARRAY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; GENE EXPRESSION; MALE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; RAT; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; UREMIA; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION; AGONISTS; ANIMAL; COMPARATIVE STUDY; DRUG EFFECTS; KIDNEY; METABOLISM; NEPHRECTOMY; SURGERY;

ANIMALS; AORTA; CALCITRIOL; ENDOTHELIUM, VASCULAR; KIDNEY; NEPHRECTOMY; RATS; RECEPTORS, CALCITRIOL; VITAMINS;

EID: 84925502689     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.12.002     Document Type: Review

References (49)

1. National-Kidney-Foundation, Chronic Kidney Disease (CKD), Retrieved from http://www.kidney.org/kidneyDisease/ckd/index.cfm (2014).
2. J.S. Zebrack, J.L. Anderson, S. Beddhu, B.D. Horne, T.L. Bair, A. Cheung, and J.B. Muhlestein Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency? J. Am. Coll. Cardiol. 42 1 2003 57 63
3. D.E. Weiner, H. Tighiouart, M.G. Amin, P.C. Stark, B. MacLeod, J.L. Griffith, D.N. Salem, A.S. Levey, and M.J. Sarnak Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies J. Am. Soc. Nephrol. 15 5 2004 1307 1315
4. A.S. Go, G.M. Chertow, D.C.E. Fan McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N. Engl. J. Med. 351 13 2004 1296 1305
5. J. Yeboah, J.R. Crouse, D.A. Bluemke, J.A. Lima, J.F. Polak, G.L. Burke, and D.M. Herrington Endothelial dysfunction is associated with left ventricular mass (assessed using MRI) in an adult population (MESA) J. Hum. Hypertens. 25 2011 25 31
6. K. Damman, P.R. Kalra, and H. Hillege Pathophysiological mechanisms contributing to renal dysfunction in chronic heart failure J. Ren. Care 36 Suppl. 1 2010 18 26
7. J. Malyszko Mechanism of endothelial dysfunction in chronic kidney disease Clin. Chim. Acta 411 19-20 2011 1412 1420
8. A. Virdis, L. Ghiadoni, D. Versari, C. Giannarelli, A. Salvetti, and S. Taddei Endothelial function assessment in complicated hypertension Curr. Pharm. Des. 14 18 2008 1761 1770
9. A.E. Caballero, S. Arora, R. Saouaf, S.C. Lim, P. Smakowski, J.Y. Park, G.L. King, F.W. LoGerfo, E.S. Horton, and A. Veves Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes Diabetes 48 9 1999 1856 1862
10. A. Levin, G.L. Bakris, M. Molitch, M. Smulders, J. Tian, L.A. Williams, and D.L. Andress Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease Kidney Int. 71 1 2007 31 38
11. J.R. Wu-Wong Endothelial dysfunction and chronic kidney disease: treatment options Curr. Opin. Investig. Drugs 9 9 2008 970 982
12. D.L. Andress Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation Kidney Int. 69 1 2006 33 43
13. R. Ebert, N. Schutze, J. Adamski, and F. Jakob Vitamin D signaling is modulated on multiple levels in health and disease Mol. Cell. Endocrinol. 248 1-2 2006 149 159
14. J.R. Wu-Wong, W. Noonan, M. Nakane, K.A. Brooks, J.A. Segreti, J.S. Polakowski, and B. Cox Vitamin D receptor activation mitigates the impact of uremia on endothelial function in the 5/6 nephrectomized rats Int. J. Endocrinol. 2010 2010 625852
15. J.R. Wu-Wong, M. Kawai, Y.W. Chen, and M. Nakane VS-105: a novel vitamin D receptor modulator with cardiovascular protective effects Br. J. Pharmacol. 164 2b 2011 551 560
16. G. Hasdan, S. Benchetrit, G. Rashid, J. Green, J. Bernheim, and M. Rathaus Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide Kidney Int. 61 2 2002 586 590
17. E. Slatopolsky, J. Finch, C. Ritter, M. Denda, J. Morrissey, A. Brown, and H. DeLuca A new analog of calcitriol, 19-nor-1,25-(OH)2D2, suppresses parathyroid hormone secretion in uremic rats in the absence of hypercalcemia Am. J. Kidney Dis. 26 5 1995 852 860
18. M. Teng, M. Wolf, E. Lowrie, N. Ofsthun, J.M. Lazarus, and R. Thadhani Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy N. Engl. J. Med. 349 5 2003 446 456
19. M. Teng, M. Wolf, M.N. Ofsthun, J.M. Lazarus, M.A. Hernan, C.A. Camargo Jr., and R. Thadhani Activated injectable vitamin D and hemodialysis survival: a historical cohort study J. Am. Soc. Nephrol. 16 4 2005 1115 1125
20. H.W. Kim, C.W. Park, Y.S. Shin, Y.S. Kim, S.J. Shin, Y.S. Kim, E.J. Choi, Y.S. Chang, and B.K. Bang Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis Nephron Clin. Pract. 102 1 2006 c21 29
21. G.H. Lee, D. Benner, D.L. Regidor, and K. Kalantar-Zadeh Impact of kidney bone disease and its management on survival of patients on dialysis J. Ren. Nutr. 17 1 2007 38 44
22. F. Tentori, W.C. Hunt, C.A. Stidley, M.R. Rohrscheib, E.J. Bedrick, K.B. Meyer, H.K. Johnson, and P.G. Zager Mortality risk among hemodialysis patients receiving different vitamin D analogs Kidney Int. 70 10 2006 1858 1865
23. M. Wolf, A. Shah, O. Gutierrez, E. Ankers, M. Monroy, H. Tamez, D. Steele, Y. Chang, C.A. Camargo Jr., M. Tonelli, and R. Thadhani Vitamin D levels and early mortality among incident hemodialysis patients Kidney Int. 72 8 2007 1004 1013
24. M. Wolf, J. Betancourt, Y. Chang, A. Shah, M. Teng, H. Tamez, O. Gutierrez, C.A. Camargo Jr., M. Melamed, K. Norris, M.J. Stampfer, N.R. Powe, and R. Thadhani Impact of activated vitamin D and race on survival among hemodialysis patients J. Am. Soc. Nephrol. 19 7 2008 1379 1388
25. C.S. Shinaberger, J.D. Kopple, C.P. Kovesdy, C.J. McAllister, D. van Wyck, S. Greenland, and K. Kalantar-Zadeh Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients Clin. J. Am. Soc. Nephrol. 3 6 2008 1769 1776
26. M. Naves-Diaz, D. Alvarez-Hernandez, J. Passlick-Deetjen, A. Guinsburg, C. Marelli, D. Rodriguez-Puyol, and J.B. Cannata-Andia Oral active vitamin D is associated with improved survival in hemodialysis patients Kidney Int. 74 8 2008 1070 1078
27. A.B. Shoben, K.D. Rudser, I.H. de Boer, B. Young, and B. Kestenbaum Association of oral calcitriol with improved survival in nondialyzed CKD J. Am. Soc. Nephrol. 19 8 2008 1613 1619
28. C.P. Kovesdy, S. Ahmadzadeh, J.E. Anderson, and K. Kalantar-Zadeh Association of activated vitamin D treatment and mortality in chronic kidney disease Arch. Intern. Med. 168 4 2008 397 403
29. A. Levin, O. Djurdjev, M. Beaulieu, and L. Er Variability and risk factors for kidney disease progression and death following attainment of stage 4CKD in a referred cohort Am. J. Kidney Dis. 52 4 2008 661 671
30. D.V. Barreto, F.C. Barreto, S. Liabeuf, M. Temmar, F. Boitte, G. Choukroun, A. Fournier, and Z.A. Massy Vitamin D affects survival independently of vascular calcification in chronic kidney disease Clin. J. Am. Soc. Nephrol. 4 6 2009 1128 1135
31. P.H. Biggar, O. Liangos, H. Fey, V.M. Brandenburg, and M. Ketteler Vitamin D, chronic kidney disease and survival: a pluripotent hormone or just another bone drug? Pediatr. Nephrol. 26 1 2011 7 18
32. A. Covic, L. Voroneanu, and D. Goldsmith The effects of vitamin D therapy on left ventricular structure and function - are these the underlying explanations for improved CKD patient survival? Nephron Clin. Pract. 116 3 2010 c187 195
33. R. Thadhani, E. Appelbaum, Y. Pritchett, Y. Chang, J. Wenger, H. Tamez, I. Bhan, R. Agarwal, C. Zoccali, C. Wanner, D. Lloyd-Jones, J. Cannata, B.T. Thompson, D. Andress, W. Zhang, D. Packham, B. Singh, D. Zehnder, A. Shah, A. Pachika, W.J. Manning, and S.D. Solomon Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial JAMA 307 7 2012 674 684
34. L.A. Bortotolotto, V. Costa-Hong, V. Jorgetti, F. Consolim-Colombo, K. Rosa, B.C. Silva, E.M. Krieger, and J.J. De Lima Vascular changes in chronic renal disease patients with secondary hyperparathyroidism J. Nephrol. 20 1 2007 66 72
35. I.L. Nilsson, J. Aberg, J. Rastad, and L. Lind Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy Surgery 126 6 1999 1049 1055
36. P. Jolma, P. Koobi, J. Kalliovalkama, H. Saha, M. Fan, J. Jokihaara, E. Moilanen, I. Tikkanen, and I. Porsti Treatment of secondary hyperparathyroidism by high calcium diet is associated with enhanced resistance artery relaxation in experimental renal failure Nephrol. Dial. Transplant. 18 12 2003 2560 2569
37. J.R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P.E. Kroeger Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells Atherosclerosis 186 1 2006 20 28
38. J.R. Wu-Wong, M. Nakane, J. Ma, X. Ruan, and P.E. Kroeger VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells J. Cell. Biochem. 100 6 2007 1395 1405
39. B. Verges Apolipoprotein A-IV in diabetes mellitus Diabetes Metab. 21 2 1995 99 105
40. H.L. Spaulding, F. Saijo, R.H. Turnage, J.S. Alexander, T.Y. Aw, and T.J. Kalogeris Apolipoprotein A-IV attenuates oxidant-induced apoptosis in mitotic competent, undifferentiated cells by modulating intracellular glutathione redox balance Am. J. Physiol. Cell Physiol. 290 1 2006 C95 C103
41. A. Kretowski, J.E. Hokanson, K. McFann, G.L. Kinney, J.K. Snell-Bergeon, D.M. Maahs, R.P. Wadwa, R.H. Eckel, L.G. Ogden, S.K. Garg, J. Li, S. Cheng, H.A. Erlich, and M. Rewers The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes Diabetologia 49 8 2006 1946 1954
42. L. Makowski, and G.S. Hotamisligil The role of fatty acid binding proteins in metabolic syndrome and atherosclerosis Curr. Opin. Lipidol. 16 5 2005 543 548
43. R.A. Hegele A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components Clin. Biochem. 31 8 1998 609 612
44. K.L. Kavanagh, H. Jornvall, B. Persson, and U. Oppermann Medium- and short-chain dehydrogenase/reductase gene and protein families: the SDR superfamily: functional and structural diversity within a family of metabolic and regulatory enzymes Cell. Mol. Life Sci. 65 24 2008 3895 3906
45. F. Labrie, V. Luu-The, S.X. Lin, C. Labrie, J. Simard, R. Breton, and A. Belanger The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology Steroids 62 1 1997 148 158
46. A. Arai, J.A. Spencer, and E.N. Olson STARS, a striated muscle activator of Rho signaling and serum response factor-dependent transcription J. Biol. Chem. 277 27 2002 24453 24459
47. K. Troidl, I. Ruding, W.J. Cai, Y. Mucke, L. Grossekettler, I. Piotrowska, H. Apfelbeck, W. Schierling, O.L. Volger, A.J. Horrevoets, K. Grote, T. Schmitz-Rixen, W. Schaper, and C. Troidl Actin-binding rho activating protein (Abra) is essential for fluid shear stress-induced arteriogenesis Arterioscler. Thromb. Vasc. Biol. 29 12 2009 2093 2101
48. C.M. Milner, and R.D. Campbell Structure and expression of the three MHC-linked HSP70 genes Immunogenetics 32 4 1990 242 251
49. I. Portig, F. Kliebe, C. Kliebe, V. Ruppert, and B. Maisch HSPA1B polymorphism in familial forms of inflammatory dilated cardiomyopathy Int. J. Cardiol. 133 1 2009 126 128